Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
GW Pharmaceuticals Plc, Medical Devices Deals, 2012 to YTD 2018 10
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Mentor Capital Invests USD1 Million in GW Pharma 12
Partnerships 13
GW Pharma Enters into Research Agreement with New South Wales 13
GW Pharma Enters Into Distribution Agreement With Ipsen For Sativex 14
Equity Offering 15
GW Pharma Raises USD345.2 Million in Public Offering of American Depositary Shares 15
GW Pharma Raises USD317.4 Million in Public Offering of Shares 17
GW Pharma Raises USD290 Million in Public Offering of American Depositary Shares 19
GW Pharma Completes Exercise of Underwriter’s Over Allotment Option for Public Offering of ADSs for USD206 Million 21
GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 23
GW Pharma Completes Public Offering Of American Depositary Shares For US$101 Million 25
GW Pharma Announces Partial Exercise Of Underwriter’s Option Of American Depository Shares For US$33 Million 27
Acquisition 29
GW Pharma May Sell Itself 29
GW Pharmaceuticals Plc – Key Competitors 30
GW Pharmaceuticals Plc – Key Employees 31
GW Pharmaceuticals Plc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Aug 07, 2018: GW Pharmaceuticals reports fiscal third quarter 2018 financial results and operational progress 33
May 08, 2018: GW Pharmaceuticals Announces Fiscal Second Quarter 2018 Financial Results 35
Feb 05, 2018: GW Pharmaceuticals Reports Q1 Fiscal 2018 Financial Results 36
Dec 04, 2017: GW Pharmaceuticals Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress 38
Aug 07, 2017: GW Pharmaceuticals Reports Fiscal Third Quarter 2017 Financial Results 40
May 09, 2017: GW Pharmaceuticals Reports Fiscal Second Quarter 2017 Financial Results and Operational Progress 42
Feb 07, 2017: GW Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Progress 44
Corporate Communications 45
Dec 21, 2017: GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors 45
May 15, 2017: GW Pharmaceuticals Announces Research & Development Management Appointments 46
Mar 07, 2017: GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director – UK 47
Legal and Regulatory 48
Aug 02, 2018: Certara Software or Services supported 95% of the US FDA novel drug approvals in first half of 2018 48
Government and Public Interest 49
Feb 23, 2017: First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GW Pharmaceuticals Plc, Deals By Therapy Area, 2012 to YTD 2018 9
GW Pharmaceuticals Plc, Medical Devices Deals, 2012 to YTD 2018 10
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Mentor Capital Invests USD1 Million in GW Pharma 12
GW Pharma Enters into Research Agreement with New South Wales 13
GW Pharma Enters Into Distribution Agreement With Ipsen For Sativex 14
GW Pharma Raises USD345.2 Million in Public Offering of American Depositary Shares 15
GW Pharma Raises USD317.4 Million in Public Offering of Shares 17
GW Pharma Raises USD290 Million in Public Offering of American Depositary Shares 19
GW Pharma Completes Exercise of Underwriter's Over Allotment Option for Public Offering of ADSs for USD206 Million 21
GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 23
GW Pharma Completes Public Offering Of American Depositary Shares For US$101 Million 25
GW Pharma Announces Partial Exercise Of Underwriter’s Option Of American Depository Shares For US$33 Million 27
GW Pharma May Sell Itself 29
GW Pharmaceuticals Plc, Key Competitors 30
GW Pharmaceuticals Plc, Key Employees 31
GW Pharmaceuticals Plc, Other Locations 32
GW Pharmaceuticals Plc, Subsidiaries 32
List of Figures
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
GW Pharmaceuticals Plc, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer